Login

Financial Snapshot

Revenue
TTM
$2.980K
Gross Margin
TTM
40.13%
Net Income
TTM
-$226.3K
Current Assets
2024 Q4
$98.20K
Current Liabilities
2024 Q4
$2.407M
Current Ratio
2024 Q4
4.08%
Total Assets
2024 Q4
$98.20K
Total Liabilities
2024 Q4
$2.449M
Book Value
2024 Q4
-2.351M
Cash
Last 4 Quarters
N/A
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $691.35 Thousand

About Pharmagreen Biotech Inc

Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The firm is engaged in developing its line of nutraceutical products, which is a blend of therapeutic plants and mushrooms. Utilizing the Company's expertise in plant genetics, its transgenic program uses the technology available to research and create nutraceuticals, and daily supplements with the potential to improve lives and address a variety of ailing conditions. The MaxGenomic Supplement is a proprietary blend that consists of nine medicinal mushrooms and six medical plants to help support the human mind and body. Its nutraceutical product, MaxGenomic Supplement, comes in a bottle of 60 enteric capsules. Its other nutraceutical products are in various development stages. Its products are marketed and are available through online stores, such as Amazon and Shopify.

Industry: Airports, Flying Fields & Airport Terminal Services Peers: Target Group Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support